Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11241 - 11248 of 12008 results
NLRB Invalidates Another Workplace Social Media Policy
November 29, 2012| Blog| Viewpoint
OCR Issues Guidance on Methods for De-Identification of PHI Under HIPAA
November 28, 2012| Blog| Viewpoint
USCIS Releases Fraud Analysis Framework for H-1 and L-1 Visas
November 26, 2012| Blog| Viewpoint
Lululemon and Calvin Klein Settle Yoga Pants Design Litigation
November 26, 2012| Blog| Viewpoint
FTC Revises "Green Guides"
November 21, 2012| Blog| Viewpoint
The Unforeseeable Transaction: Apple Argues that the California Song-Beverly Credit Card Act Should Not Apply To Online Retailers
November 20, 2012| Blog| Viewpoint
From Brussels: The New EU Data Protection Regulation -- Will they or won't they? And if so, when?
November 19, 2012| Blog| Viewpoint
DOJ and SEC Issue Highly Anticipated FCPA Guidance
November 15, 2012| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|